Literature DB >> 60515

Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease.

R G Long, R K Skinner, M R Wills, S Sherlock.   

Abstract

Serum-25-hydroxy-vitamin-D (25 OHD) concentration has been measured in 106 patients with untreated parenchymal and cholestatic liver disease. Low mean values were found in groups of patients with alcoholic hepatitis and cirrhosis, non-cirrhotic active chronic hepatitis, lupoid and cryptogenic cirrhosis, symptomatic primary biliary cirrhosis, and acute and chronic biliary disease. In a group of patients with presymptomatic biliary cirrhosis the mean value was not significantly different from normal. It is concluded that in the presence of significant parenchymal or cholestatic liver disease serum-25-OHD concentrations are usually low. The mechanisms for the reduction remain to be clarified, but low serum-25-OHD values may play a contributory role in the aetiology of osteomalacia in chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60515     DOI: 10.1016/s0140-6736(76)92463-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Abnormal vitamin D metabolism in cirrhosis.

Authors:  R T Jung; M Davie; J O Hunter; T M Chalmers; D E Lawson
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

Review 2.  Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases.

Authors:  J A Jorge-Hernandez; C E Gonzalez-Reimers; A Torres-Ramirez; F Santolaria-Fernandez; C Gonzalez-Garcia; J N Batista-Lopez; M Pestana-Pestana; L Hernandez-Nieto
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

Review 3.  Persistence in herpes simplex virus infections.

Authors:  M Longson
Journal:  Postgrad Med J       Date:  1978-09       Impact factor: 2.401

4.  Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.

Authors:  D D Bikle; B P Halloran; E Gee; E Ryzen; J G Haddad
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 5.  Vitamin D deficient states. Pathophysiology and treatment.

Authors:  M D Jacobs
Journal:  West J Med       Date:  1979-10

Review 6.  Drugs and vitamin deficiency.

Authors:  L Ovesen
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

Review 7.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

8.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

9.  Serum 25-hydroxyvitamin D levels in thalassaemia.

Authors:  S Tsitoura; N Amarilio; P Lapatsanis; S Pantelakis; S Doxiadis
Journal:  Arch Dis Child       Date:  1978-04       Impact factor: 3.791

10.  Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; R P Thompson
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.